Cory S. Freedland insider trades

Open-market stock purchases and sales by Cory S. Freedland, Director at Neurogene Inc, from SEC Form 4 filings since Jan 16, 2024.

Recent trades

DateStockTradeValue
Feb 20, 2026NGNE Neurogene IncBought (not open market)—

Companies traded

  • NGNE Neurogene Inc: other filings, last Feb 20, 2026

Get free alerts when Cory S. Freedland files a new trade →